Cosopt is a combination glaucoma medication. Which two drugs constitute this product?

Study for the NBEO Part II TMOD Exam. Prepare with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam!

Multiple Choice

Cosopt is a combination glaucoma medication. Which two drugs constitute this product?

Explanation:
Cosopt is defined by two active components that work in different ways to lower intraocular pressure. One is timolol, a nonselective beta-blocker that decreases aqueous humor production by blocking beta receptors in the ciliary body. The other is dorzolamide, a carbonic anhydrase inhibitor that also reduces aqueous humor formation by limiting bicarbonate production in the ciliary processes. Using these two together provides an additive effect, making it effective when single-drug therapy isn’t enough. The two drugs in Cosopt are timolol and dorzolamide. Other fixed combinations pair different drugs (for example, a prostaglandin analog with a beta-blocker or a brimonidine-based mix), so they are not Cosopt.

Cosopt is defined by two active components that work in different ways to lower intraocular pressure. One is timolol, a nonselective beta-blocker that decreases aqueous humor production by blocking beta receptors in the ciliary body. The other is dorzolamide, a carbonic anhydrase inhibitor that also reduces aqueous humor formation by limiting bicarbonate production in the ciliary processes. Using these two together provides an additive effect, making it effective when single-drug therapy isn’t enough. The two drugs in Cosopt are timolol and dorzolamide. Other fixed combinations pair different drugs (for example, a prostaglandin analog with a beta-blocker or a brimonidine-based mix), so they are not Cosopt.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy